No results for ‘’
Fundviser Capital (India) Ltd
NSE: BSE: 530197
₹395
(0%)
Mon, 27 Jul 2026, 05:24 pm
Market Cap (in Cr)312.05
PE Ratio186.20
Dividend0
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
Fundviser Capital (India) Analysis
dividend
Pros
Cons
- Unable to evaluate Fundviser Capital (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Fundviser Capital (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.
health
Pros
- Fundviser Capital (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Fundviser Capital (India) is profitable, therefore cash runway is not a concern.
- Fundviser Capital (India) is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 269x debt.
- Fundviser Capital (India) has no long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (11.5% vs 0.3% today).
- Interest payments on debt are well covered by earnings (EBIT is 89.8x coverage).
- Fundviser Capital (India)'s level of debt (0.3%) compared to net worth is satisfactory (less than 40%).
- Low level of unsold assets.
Cons
- Operating cash flow is negative therefore debt is not well covered.
management
Pros
- Prachi's remuneration is lower than average for companies of similar size in India.
Cons
- The average tenure for the Fundviser Capital (India) board of directors is less than 3 years, this suggests a new board.
- The average tenure for the Fundviser Capital (India) management team is less than 2 years, this suggests a new team.
misc
Pros
Cons
- Fundviser Capital (India) is not covered by any analysts.
- Fundviser Capital (India) has significant price volatility in the past 3 months.
past
Pros
- Fundviser Capital (India) has delivered over 20% year on year earnings growth in the past 5 years.
- Fundviser Capital (India) has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Cons
- Fundviser Capital (India)'s 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Fundviser Capital (India) used its assets less efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Fundviser Capital (India) has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Fundviser Capital (India)'s 1-year earnings growth is negative, it can't be compared to the IN Chemicals industry average.
value
Pros
- Fundviser Capital (India) is good value based on assets compared to the IN Chemicals industry average.
Cons
- Fundviser Capital (India) is overvalued based on earnings compared to the IN Chemicals industry average.
- Fundviser Capital (India) is overvalued based on earnings compared to the India market.
- 530197 underperformed the Chemicals industry which returned 2.2% over the past year.
- 530197 underperformed the Market in India which returned -14.5% over the past year.
- BSE:530197 is down -30.6% underperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:530197 is down -30.6% underperforming the market in India which returned 8% over the past month.